Ë¿¹ÏÊÓƵAPP

Ë¿¹ÏÊÓƵAPP's Mike Cusumano explains how through cross-functional collaboration insurers can apply data analysis to refine and improve complex case underwriting. Read Part II of this article series to learn how additional and more complex analyses can provide more precise – ...

The future of quantum computing has already begun, and the implications for the insurance industry are profound. Insurers would be well served to take steps now to determine how quantum computing might impact their businesses moving forward.

In this article, we discuss Ë¿¹ÏÊÓƵAPP’s latest behavioral science research, which assessed the trade-offs between optimizing questions for alcohol and smoking disclosure, applicants’ experience of answering the questions, and what the results might teach about designing si...

This article, the first of two parts, provides a clinical review of ASD, and the second part, in the September issue of ReFlections, will focus on insurance medicine’s view and assessment of ASD.

Ë¿¹ÏÊÓƵAPP's Dr. Dan Zimmerman reviews recent controversies and developments in aging research and updates what to anticipate in the coming years.

Information collected on occupational duties claims forms is often inadequate. In this article, Ë¿¹ÏÊÓƵAPP's Peter Hovard shares the findings of a large study conducted in key markets and explains why behavioral science-backed enhancements to claim forms improve information...

Tina Paap has been with Ë¿¹ÏÊÓƵAPP for 23 years, most recently in the role of Vice President of Claims for Ë¿¹ÏÊÓƵAPP Asia, and prior to retirement shared her top 10 tips for claims management.

Life and health insurance coverage and distribution are evolving. In this article, Jaqui Wa...

Human consumption of microplastics (MPs) is increasing. Initial research suggests that MPs may negatively impact human health, but evidence to quantify that impact is currently insufficient.

In this , Ë¿¹ÏÊÓƵAPP's Catie Muccigrosso explains why, as accelerated underwriting evolves, insurers will benefit...

Ë¿¹ÏÊÓƵAPP has worked with insurers around the globe to support the development of life and health insurance products that have a positive environmental, social, or governance (ESG) impact, in line with our purpose to make financial protection accessible to all. These prote...

Ë¿¹ÏÊÓƵAPP's Petr Vaclav explains how behavioral and contextual signals can improve the life insurance value chain. Curious about Ë¿¹ÏÊÓƵAPP's data insights?  

Curious about Ë¿¹ÏÊÓƵAPP's medical insights?   Conta...

Alternative data sources and supporting technologies are propelling today’s advances in underwriting, enabling acceleration. Accelerated underwriting is empowering insurers to speed processes and improve the customer experience. 

Much of the available data regarding the therapeutic use of psychedelics for mental health disorders remains introductory; however, momentum is building with the potential to offer unique treatments for many complex mental health disorders.

New pharmaceuticals to treat sickle cell disease (SCD) are steadily improving the health and wellbeing of many people living with this chronic disorder. It is hoped that revolutionary gene therapies now in clinical trials will be able to cure more SCD patients. The r...

GPT-4 features stronger safety and privacy guardrails, longer input and output text, and more accurate, detailed, and concise responses for nuanced questions. Although it offers exciting opportunities for insurance and countless other industries, its potential provid...

Many health insurers exclude experimental treatments without clearly defining which treatments they would consider experimental. In this Global Health Brief, Ë¿¹ÏÊÓƵAPP's Colin Weston discusses the need for clear definitions in policy language. He also explores how drugs, t...